Skip to main content

Table 2 Characteristics of patients with suspected myocarditis and controls

From: A novel multiparametric imaging approach to acute myocarditis using T2-mapping and CMR feature tracking

Parameter

Controls

Myocarditis patients

p-value

Number

17

67

n.a.

Females / Males

6/11

18/49

n.a.

Age [years]

36 ± 12

37 ± 14

.849

Height [cm]

178 ± 11

177 ± 9

.788

Weight [kg]

77 ± 14

79 ± 14

.671

Heart rate [bpm]

63 ± 15

65 ± 13

.743

Symptom duration before CMR [days]

n.a.

4.8 ± 4.4

n.a.

Initial TnT [μg/l]

n.a.

3.0 ± 16.1

n.a.

Initial NT-proBNP [pg/ml]

n.a.

2380 ± 5535

n.a.

Initial CK [U/l]

n.a.

2942 ± 1719

n.a.

Initial CRP [mg/l]

n.a.

37.4 ± 43.5

n.a.

LVa EDb volume / BSAc [ml/m2]

81 ± 14

84 ± 21

.486

LV ESd volume / BSA [ml/m2]

29 ± 8

33 ± 10

.081

LV ejection fraction [%]

65 ± 5

62 ± 7

.032

LV ED wall mass / BSA [g/m2] (without papillary muscles)

47 ± 11

54 ± 15

.026

T2-Ratio

1.8 ± 1.4

2.2 ± 0.9

.097

≥ 2 out of 3 LLCe [%]

0

57

n.a.

1 out of 3 LLC [%]

24

27

n.a.

0 out of 3 LLC [%]

76

16

n.a.

  1. a LV left ventricle, b ED end diastolic, c BSA body surface area, d ES end systolic, e LLC Lake Louise criteria
  2. Statistical significant p values are printed in bold face